Article
Rheumatology
Kelvin Y. C. Yu, Susan Yung, Mel K. M. Chau, Colin S. O. Tang, Desmond Y. H. Yap, Alexander H. N. Tang, Shirley K. Y. Ying, Cheuk Kwong Lee, Tak Mao Chan
Summary: The study found that levels of syndecan-1, HA, and thrombomodulin were significantly elevated in patients with active lupus nephritis and correlated with various clinical parameters. Longitudinal studies showed that syndecan-1 and thrombomodulin levels increased before clinical renal flare, while HA levels increased at the time of nephritic flare. These biomarkers have the potential to differentiate between active lupus nephritis and other conditions, and may provide insight into the pathogenesis of the disease.
Article
Multidisciplinary Sciences
Keiko Suzuki, Hideshi Okada, Kazuyuki Sumi, Hiroyuki Tomita, Ryo Kobayashi, Takuma Ishihara, Yoshinori Kakino, Kodai Suzuki, Naomasa Yoshiyama, Ryu Yasuda, Yuichiro Kitagawa, Tetsuya Fukuta, Takahito Miyake, Haruka Okamoto, Tomoaki Doi, Takahiro Yoshida, Shozo Yoshida, Shinji Ogura, Akio Suzuki
Summary: The study found that changing serum SDC-1 levels can help early detection of organ dysfunction in critically ill patients, with significant effects on multiple outcomes seen from the previous day's SDC-1 levels. Furthermore, increasing levels of SDC-1 were identified as a significant risk factor for mortality.
SCIENTIFIC REPORTS
(2021)
Article
Multidisciplinary Sciences
Gia Deyab, Trine Marita Reine, Tram Thu Vuong, Trond Jenssen, Gunnbjorg Hjeltnes, Stefan Agewall, Knut Mikkelsen, Oystein Forre, Morten Wang Fagerland, Svein Olav Kolset, Ivana Hollan
Summary: The study found that treatment with disease-modifying antirheumatic drugs can decrease serum levels of syndecan-1 in patients with rheumatoid arthritis, reducing shedding of syndecan-1 from the endothelial glycocalyx and potentially providing cardioprotective effects.
Article
Multidisciplinary Sciences
Hideaki Oiwa, Hideshi Okada, Keiko Suzuki, Kazuyuki Sumi, Shozo Yoshida, Kodai Suzuki, Takuma Ishihara, Hiroki Kitagaki, Kaori Kimura, Yoshihito Naito, Naokazu Chiba, Ayumi Kuroda, Akihiro Uchida, Hirotsugu Fukuda, Yuki Kawasaki, Toru Minamiyama, Ayane Nishio, Takuto Shimada, Ryo Kamidani, Tomotaka Miura, Ryota Tochibora, Saori Yamamoto, Yujiro Kinomura, Yuichiro Kitagawa, Tetsuya Fukuta, Takahito Miyake, Takahiro Yoshida, Akio Suzuki, Nobuyuki Tetsuka, Hiroyuki Tomita, Takahide Nawa, Shinji Ogura
Summary: Intradialytic hypotension and arrhythmias are common complications of hemodialysis. Impairment of the vascular endothelial glycocalyx has been suggested to be associated with these complications. This study found a positive correlation between the change in syndecan-1 levels and the incidence of hemodialysis complications. These findings suggest that impairment of the vascular endothelial glycocalyx may be a possible cause of intradialytic hypotension.
SCIENTIFIC REPORTS
(2023)
Article
Gastroenterology & Hepatology
Doron Yablecovitch, Shomron Ben-Horin, Orit Picard, Miri Yavzori, Ella Fudim, Moshe Nadler, Idan Levy, Emad Sakhnini, Alon Lang, Tal Engel, Maor Lahav, Talia Saker, Sandra Neuman, Limor Selinger, Revital Dvir, Maria Raitses-Gurevich, Talia Golan, Ido Laish
Summary: The study suggests that serum SDC1 is a promising novel biomarker for the early blood-based diagnosis of pancreatic cancer.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
(2022)
Review
Cell Biology
Andrea Reszegi, Peter Tatrai, Eszter Regos, Ilona Kovalszky, Kornelia Baghy
Summary: Syndecan-1 is a protein that regulates cell activities and plays a crucial role in liver diseases and hepatocellular carcinoma. It is involved in various physiological and pathological processes, including cell proliferation, inflammation, and matrix remodeling.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
(2022)
Review
Biochemistry & Molecular Biology
John R. Couchman
Summary: Cell surface proteoglycans, such as syndecans, play crucial roles in regulating cell behavior, including interactions with extracellular matrix components and mediating proliferation, adhesion, and migration. In tumors, changes in the levels and distribution of syndecan-1 can have implications for prognosis, with loss of membrane staining and abnormal cytoplasmic or nuclear staining often indicating poor outcomes. Targeting syndecan-1 with antibody-toxin conjugates may hold promise for clinical applications in both myeloma and some carcinomas.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Endocrinology & Metabolism
Einas H. Alkhatib, Jody B. Grundman, Anna M. Adamusiak, Melena D. Bellin, Joel P. Brooks, Kevin S. Buckley, Erin M. Janssen, Maleewan Kitcharoensakkul, Kyle P. Mcnerney, Thea L. Pfeifer, Brooke I. Polk, Brynn E. Marks
Summary: Insulin hypersensitivity reactions are rare but serious complications of T1D treatment, negatively affecting glycemic control and quality of life.
FRONTIERS IN ENDOCRINOLOGY
(2023)
Article
Medicine, General & Internal
Keigo Kusuzawa, Keiko Suzuki, Hideshi Okada, Kodai Suzuki, Chihiro Takada, Soichiro Nagaya, Ryu Yasuda, Haruka Okamoto, Takuma Ishihara, Hiroyuki Tomita, Yuki Kawasaki, Toru Minamiyama, Ayane Nishio, Hirotsugu Fukuda, Takuto Shimada, Yuto Tamaoki, Tomoki Yoshida, Yusuke Nakashima, Naokazu Chiba, Genki Yoshimura, Ryo Kamidani, Tomotaka Miura, Hideaki Oiwa, Fuminori Yamaji, Yosuke Mizuno, Takahito Miyake, Yuichiro Kitagawa, Tetsuya Fukuta, Tomoaki Doi, Akio Suzuki, Takahiro Yoshida, Nobuyuki Tetsuka, Shozo Yoshida, Shinji Ogura
Summary: The study aimed to assess endothelial injury using serum syndecan-1 as a marker in hemodialysis patients. Results showed a significant increase in serum syndecan-1 concentration before and after hemodialysis, with a positive correlation between dialysis time and syndecan-1 concentration changes, while the amount of body fluid removed was not significantly correlated with syndecan-1 concentration changes.
FRONTIERS IN MEDICINE
(2021)
Article
Medicine, General & Internal
Ayane Nishio, Ryo Kamidani, Hideshi Okada, Keiko Suzuki, Kodai Suzuki, Takahito Miyake, Haruka Okamoto, Tomoaki Doi, Akio Suzuki, Shozo Yoshida, Shinji Ogura
Summary: This case report illustrates the clinical manifestations of a patient with HELLP syndrome and their correlation with serum syndecan-1 (SDC-1) levels. It is found that SDC-1 levels are significantly elevated in patients with HELLP syndrome before and after pregnancy termination, which is closely associated with the severity of the disease.
FRONTIERS IN MEDICINE
(2023)
Article
Medicine, General & Internal
Balazs Sagi, Szilard Kun, Rita Klaudia Jakabfi-Csepregi, Endre Sulyok, Botond Csiky
Summary: This study found that acute vascular changes occur in chronic hemodialysis patients during the dialysis process, mediated by factors related to the endothelium. These changes are correlated with cardiovascular risk factors.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Pharmacology & Pharmacy
Sofie Broeng-Mikkelgaard, Julie Maria Boggild Brosen, Peter Lommer Kristensen, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard
Summary: Insulin therapy has evolved and new insulin analogs have been developed, but hypoglycemia remains a major side effect. Current insulin trials often exclude high-risk individuals, underestimating the clinical impact and pharmacoeconomic effect of new insulins. New research shows that high-risk individuals have better treatment outcomes in reducing hypoglycemia.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Endocrinology & Metabolism
Gemma Llaurado, Nuria Amigo, Rocio Fuertes-Martin, Ana Romero, Albert Cano, Lara Albert, Olga Gimenez-Palop, Eugenio Berlanga, Sonia Fernandez-Veledo, Xavier Correig, Joan Vendrell, Jose-Miguel Gonzalez-Clemente
Summary: This study evaluated the utility of measuring serum GlycA and GlycB to assess vascular aging in adults with type 1 diabetes (T1D) of more than 10 years duration and no previous cardiovascular events. The results showed that GlycA and GlycB were positively correlated with the surrogate measure of arterial stiffness (aPWV) and independently associated with aPWV. Therefore, measuring serum GlycA and GlycB may be helpful in assessing vascular aging in adults with T1D.
Article
Endocrinology & Metabolism
Lei Zhang, Bi Lu, Wenhua Wang, Shifeng Miao, Shuru Zhou, Xingbo Cheng, Jie Zhu, Changmei Liu
Summary: In patients with gestational diabetes mellitus (GDM), lower circulating Neuregulin 4 (Nrg4) and higher Neuregulin 1 (Nrg1) levels were observed, along with increased inflammatory factors. Nrg4 showed negative correlations with various metabolic indicators, while Nrg1 was positively correlated with BMI and other markers. The decrease of Nrg4 and increase of Nrg1 were associated with higher prevalence of GDM, and the combination of Nrg1 with IL-6 and TNF-alpha could potentially be an effective screening tool for GDM.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM
(2021)
Article
Biochemistry & Molecular Biology
Eleni Koliakou, Manthou Maria Eleni, Ioanna Koumentakou, Nikolaos Bikiaris, Polyanthi Konstantinidou, Patricia Rousselle, Doxakis Anestakis, Elisabeth Lazaridou, Evangelia Kalloniati, Dimosthenis Miliaras, Anna Michopoulou
Summary: Syndecan-1 and -4 expression is altered in psoriasis, and fibronectin expression is decreased. Psoriatic keratinocytes showed increased cell growth and pro-inflammatory cytokine release on fibronectin. Co-culture experiments suggest fibroblast-released factors may down-regulate syndecan-1 expression on keratinocytes plated on fibronectin.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)